Il y a eu 50 transactions d'initiés récentes enregistrées pour MediciNova, Inc. (MNOV), dont 35 achats et 11 ventes. Le total des achats d'initiés s'élève à $14.79M et le total des ventes d'initiés à $824.22K.
Les initiés notables ayant une activité récente comprennent Iwaki Yuichi, Matsuda Kazuko, Nagao Hideki. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — MNOV
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-01-16 |
Iwaki Yuichi |
President and CEO |
Attribution de RSU |
450,000 |
$2.10 |
$945K |
450,000 |
| 2026-01-16 |
Matsuda Kazuko |
Chief Medical Officer |
Attribution de RSU |
350,000 |
$2.10 |
$735K |
350,000 |
| 2025-06-17 |
Nagao Hideki |
Director |
Attribution de RSU |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-06-17 |
Beaver Carolyn |
Director |
Attribution de RSU |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-06-17 |
Lemerond Nicole |
Director |
Attribution de RSU |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-02-12 |
Iwaki Yuichi |
President and CEO |
Attribution de RSU |
100,000 |
$1.84 |
$184K |
100,000 |
| 2025-02-12 |
Nagao Hideki |
Director |
Attribution de RSU |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-02-12 |
Beaver Carolyn |
Director |
Attribution de RSU |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-02-12 |
Matsuda Kazuko |
Chief Medical Officer |
Attribution de RSU |
100,000 |
$1.84 |
$184K |
100,000 |
| 2025-02-12 |
Lemerond Nicole |
Director |
Attribution de RSU |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-01-07 |
Iwaki Yuichi |
President and CEO |
Attribution de RSU |
400,000 |
$1.52 |
$608K |
400,000 |
| 2025-01-07 |
Matsuda Kazuko |
Chief Medical Officer |
Attribution de RSU |
300,000 |
$1.52 |
$456K |
300,000 |
| 2024-06-11 |
Nagao Hideki |
Director |
Attribution de RSU |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-06-11 |
Beaver Carolyn |
Director |
Attribution de RSU |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-06-11 |
Lemerond Nicole |
Director |
Attribution de RSU |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-01-09 |
Iwaki Yuichi |
President and CEO |
Attribution de RSU |
210,000 |
$2.40 |
$504K |
210,000 |
| 2024-01-09 |
Matsuda Kazuko |
Chief Medical Officer |
Attribution de RSU |
157,500 |
$2.40 |
$378K |
157,500 |
| 2024-01-09 |
Obrien Geoffrey |
Vice President |
Attribution de RSU |
84,000 |
$2.40 |
$201.6K |
84,000 |
| 2023-08-04 |
Lemerond Nicole |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-08-04 |
Lemerond Nicole |
Director |
Attribution de RSU |
18,333 |
$2.47 |
$45.28K |
18,333 |
| 2023-06-13 |
Nagao Hideki |
Director |
Attribution de RSU |
20,000 |
$2.23 |
$44.6K |
20,000 |
| 2023-06-13 |
Beaver Carolyn |
Director |
Attribution de RSU |
20,000 |
$2.23 |
$44.6K |
20,000 |
| 2023-01-23 |
Iwaki Yuichi |
President and CEO |
Attribution de RSU |
235,125 |
- |
- |
235,125 |
| 2023-01-23 |
Matsuda Kazuko |
Chief Medical Officer |
Attribution de RSU |
149,625 |
- |
- |
149,625 |
| 2023-01-23 |
Obrien Geoffrey |
Vice President |
Attribution de RSU |
76,950 |
- |
- |
76,950 |
| 2022-11-28 |
Nagao Hideki |
Director |
Vente Informative |
6,754 |
$2.25 |
$15.2K |
- |
| 2022-11-22 |
Nagao Hideki |
Director |
Vente Informative |
218 |
$2.13 |
$464.34 |
6,754 |
| 2022-11-21 |
Nagao Hideki |
Director |
Vente Informative |
5,365 |
$2.18 |
$11.7K |
6,972 |
| 2022-11-17 |
Nagao Hideki |
Director |
Vente Informative |
309 |
$2.18 |
$673.62 |
12,337 |
| 2022-06-16 |
Nagao Hideki |
Director |
Attribution de RSU |
20,000 |
- |
- |
20,000 |
| 2022-06-16 |
Beaver Carolyn |
Director |
Attribution de RSU |
20,000 |
$2.51 |
$50.2K |
20,000 |
| 2022-06-16 |
Kruger Jason J |
Officer |
Inconnu |
- |
- |
- |
- |
| 2022-01-27 |
Iwaki Yuichi |
President and CEO |
Attribution de RSU |
302,500 |
$5.92 |
$1.79M |
302,500 |
| 2022-01-27 |
Matsuda Kazuko |
Chief Medical Officer |
Attribution de RSU |
192,500 |
$5.92 |
$1.14M |
192,500 |
| 2022-01-27 |
Obrien Geoffrey |
Vice President |
Attribution de RSU |
99,000 |
$5.92 |
$586.08K |
99,000 |
| 2021-08-23 |
Matsuda Kazuko |
Chief Medical Officer |
Exercice d'Options (Vente) |
60,000 |
$2.30 |
$138K |
- |
| 2021-08-01 |
Paulin Douglas |
Officer |
Inconnu |
- |
- |
- |
- |
| 2021-07-09 |
Iwaki Yuichi |
President and CEO |
Exercice d'Options (Vente) |
39,583 |
$2.54 |
$100.54K |
- |
| 2021-06-24 |
Matsuda Kazuko |
Chief Medical Officer |
Exercice d'Options (Vente) |
56,250 |
$2.46 |
$138.38K |
- |
| 2021-06-16 |
Nagao Hideki |
Director |
Attribution de RSU |
20,000 |
$3.95 |
$79K |
20,000 |
| 2021-06-16 |
Beaver Carolyn |
Director |
Attribution de RSU |
20,000 |
$3.95 |
$79K |
20,000 |
| 2021-05-19 |
Obrien Geoffrey |
Vice President |
Exercice d'Options (Vente) |
32,000 |
$2.54 |
$81.28K |
- |
| 2021-04-22 |
Gaeta Federico C.a. |
Chief Scientific Officer |
Cession |
20,000 |
$5.42 |
$108.4K |
- |
| 2021-04-22 |
Gaeta Federico C.a. |
Chief Scientific Officer |
Attribution de RSU |
24,000 |
$4.56 |
$109.44K |
24,000 |
| 2021-03-11 |
Nagao Hideki |
Director |
Vente Informative |
2,354 |
$7.40 |
$17.42K |
12,646 |
| 2021-02-25 |
Iwaki Yuichi |
President and CEO |
Exercice d'Options (Vente) |
86,250 |
$2.46 |
$212.18K |
- |
| 2021-02-02 |
Iwaki Yuichi |
President and CEO |
Attribution de RSU |
495,000 |
$6.89 |
$3.41M |
495,000 |
| 2021-02-02 |
Matsuda Kazuko |
Chief Medical Officer |
Attribution de RSU |
325,000 |
$6.89 |
$2.24M |
325,000 |
| 2021-02-02 |
Obrien Geoffrey |
Vice President |
Attribution de RSU |
99,000 |
$6.89 |
$682.11K |
99,000 |
| 2021-01-11 |
3d Investment Partners Pte. Ltd. |
10 Percent Owner |
Inconnu |
456,637 |
- |
- |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
